Clinical Trials Browser

Phase 2 × Esophageal Squamous Cell Carcinoma × Folfox protocol × Clear all

NCT00381706 2021-09-29

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Phase 2 Completed

245 enrolled 15 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01248299 2019-05-16

E-DIS

Phase 2 Terminated

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01605305 2012-05-24

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma